Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Forgotten Primodos story and the roles of general practitioners

Heneghan C. and Aronson J., (2020), BMJ Evidence-Based Medicine

Naltrexone–bupropion (Mysimba) in management of obesity: A systematic review and meta-analysis of unpublished clinical study reports

Onakpoya IJ. et al, (2020), British Journal of Clinical Pharmacology

Extending anticoagulation treatment for unprovoked venous thromboembolism.

Heneghan C. and Aronson J., (2019), BMJ evidence-based medicine

Trends in kidney function testing in UK primary care since the introduction of the quality and outcomes framework: a retrospective cohort study using CPRD.

Feakins B. et al, (2019), BMJ Open, 9

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: A systematic review of the world literature (BMC Med. (2016) 14 (10) DOI: 10.1186/s12916-016-0553-2)

Onakpoya IJ. et al, (2019), BMC Medicine, 17

Adverse events in people taking macrolide antibiotics versus placebo for any indication

Hansen MP. et al, (2019), Cochrane Database of Systematic Reviews, 2019

Introducing the EBM Verdict: Research evidence relevant to clinical practice

Heneghan C. et al, (2019), BMJ Evidence-Based Medicine

Lorcaserin in obesity: Minimal benefits and ill-defined harms

Onakpoya IJ. and Aronson JK., (2019), BMJ Evidence-Based Medicine

Medical Devices: Classification and Analysis of Faults Leading to Harms

Ferner RE. and Aronson JK., (2019), Drug Safety

Medical Devices: Definition, Classification, and Regulatory Implications

Aronson JK. et al, (2019), Drug Safety

Susceptibility to adverse drug reactions

Ferner R. and Aronson J., (2019), British Journal of Clinical Pharmacology

The British Pharmacological Society's WDM Paton Memorial Lecture 2019: How doctors were informed about pharmaceutical products through advertising in the British Medical Journal from 1955/6 to 1985/6

Aronson JK. and Green AR., (2019), British Journal of Clinical Pharmacology, 85, 1901 - 1906

Withdrawn medicines included in the essential medicines lists of 136 countries

Charles O. et al, (2019), PloS one, 14

Practice variation in the use of tests in UK primary care: A retrospective analysis of 16 million tests performed over 3.3 million patient years in 2015/16

O'Sullivan JW. et al, (2018), BMC Medicine, 16

A word about evidence: 'rapid reviews' or 'restricted reviews'?

(2018), BMJ evidence-based medicine, 23, 204 - 205

Correction: Variation in diagnostic test requests and outcomes: A preliminary metric for OpenPathology.net (Scientific Reports DOI: 10.1038/s41598-018-23263-z)

O'Sullivan JW. et al, (2018), Scientific Reports, 8

Redefining rapid reviews: a flexible framework for restricted systematic reviews

Plüddemann A. et al, (2018), BMJ evidence-based medicine, 23, 201 - 203

Reduced Salt Intake for Heart Failure: A Systematic Review

Mahtani KR. et al, (2018), JAMA Internal Medicine, 178, 1693 - 1700

Variation in diagnostic test requests and outcomes: A preliminary metric for OpenPathology.net

O'Sullivan JW. et al, (2018), Scientific Reports, 8

Diagnostic test guidelines based on high-quality evidence had greater rates of adherence: a meta-epidemiological study

(2018), Journal of Clinical Epidemiology, 103, 40 - 50

Load More

1
2
3
4
5
6
7
...
»